Showing results (11-20 of 38) with videos related to
Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|February 15, 2002
A new class of type I protein geranylgeranyltransferase (GGTase I) inhibitorSatoshi Sunami, Mitsuru Ohkubo, Takeshi Sagara, et al.Nippon Ganka Gakkai Zasshi|September 15, 2012
[Fundus photoplanimetry of the optic nerve head in the Sakurae Study]Masaki Tanito, Takeshi Sagara, Michiya Takamatsu, et al.Journal of Medicinal Chemistry|September 15, 2006
Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivityYufu Sagara, Takeshi Sagara, Minaho Uchiyama, et al.Bioorganic & Medicinal Chemistry Letters|May 10, 2006
Identification of potent 5-pyrimidinyl-2-aminothiazole CDK4, 6 inhibitors with significant selectivity over CDK1, 2, 5, 7, and 9Tadashi Shimamura, Jun Shibata, Hideki Kurihara, et al.Investigative Ophthalmology & Visual Science|April 4, 2008
Induction by latanoprost of collagen gel contraction mediated by human tenon fibroblasts: role of intracellular signaling moleculesYang Liu, Ji-Ae Ko, Ryoji Yanai, et al.Journal of Medicinal Chemistry|February 8, 2002
Cyclohexylmethylpiperidinyltriphenylpropioamide: a selective muscarinic M(3) antagonist discriminating against the other receptor subtypesYufu Sagara, Takeshi Sagara, Toshiaki Mase, et al.Journal of Personalized Medicine|December 23, 2022
The Efficacy, Safety, and Satisfaction Associated with Switching from Brinzolamide or Brimonidine to Brinzolamide/Brimonidine in Open-Angle Glaucoma PatientsHiromitsu Onoe, Kazuyuki Hirooka, Mikio Nagayama, et al.Masui. the Japanese Journal of Anesthesiology|November 30, 2006
[General anesthesia for thyroplasty employing voice test]Takao Muto, Kazuhiro Nakamura, Takeshi Sagara, et al.Journal of Clinical Medicine|July 27, 2024
The Efficacy and Safety Associated with Switching from Concomitant Brimonidine and Ripasudil, or Brimonidine or Ripasudil Monotherapy to a Fixed Combination of Brimonidine and Ripasudil in Glaucoma PatientsHiromitsu Onoe, Kazuyuki Hirooka, Tetsuya Baba, et al.Journal of Clinical Medicine|November 27, 2021
The Efficacy, Safety and Satisfaction Associated with Switching from Brinzolamide 1% and Brimonidine 0.1% to a Fixed Combination of Brinzolamide 1% and Brimonidine 0.1% in Glaucoma PatientsHiromitsu Onoe, Kazuyuki Hirooka, Mikio Nagayama, et al.Pageof 4